Migraine :: Employers who recognize the impact of migraine may help to improve workplace productivity

Migraines take a toll on employers as well ? up to $28.7 billion in annual direct and indirect healthcare costs can be attributed to migraine-related losses in productivity. Data presented today at the 59th Annual Meeting of the American Academy of Neurology (AAN) in Boston, Mass., reinforced the benefit for employers to acknowledge and assess the impact of migraine to potentially improve workplace productivity.

HIV :: Resistant HIV quickly hides in infants’ cells

New evidence shows that drug-resistant virus passed from mother-to-child can quickly establish itself in infants? CD4+ T cells where it can hide for years, likely limiting their options for future treatment. The study is published in the May 15 issue of The Journal of Infectious Diseases, now available online.

Back Pain :: 5 ways you can beat lower back pain

The National Institutes of Health estimates that eight out of ten people will suffer from back pain, making it one of the most common medical problems today. The good news is that you can treat it, minimize it, and even prevent it by following some back-friendly guidelines.

Mental Health :: Top five myths about mental illness

The stigma of mental illness acts as a roadblock for treatment for the more than 54 million Americans, one in 5, according to the National Institute on Mental Health, who suffer from a mental disorder in any given year. Of that number, many don?t seek treatment, at a time when awareness about mental illness has grown.

Liver :: Liver stiffness indicates portal hypertension

Measuring liver stiffness using transient elastography can predict severe portal hypertension in patients with hepatitis C-related cirrhosis, according to a new study in the May issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD).

Breast Cancer :: Combination treatment stymies breast cancer growth

A combination of three different drugs that block the HER-2 receptor, a critical cellular growth signal for some breast cancers, eradicated aggressive breast tumors in mice and could point the way toward developing better treatments in patients, said researchers from the Breast Center at Baylor College of Medicine in a report that appears today in the Journal of the National Cancer Institute.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack